🔗 Visit the ClinicalTrials.gov page for NCT01700049
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. | N Engl J Med | 2009 | 8.55 |
| 2 | Efficacy and safety of vismodegib in advanced basal-cell carcinoma. | N Engl J Med | 2012 | 6.90 |
| 3 | Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. | N Engl J Med | 2012 | 4.19 |
| 4 | Aggressive basal cell carcinoma: presentation, pathogenesis, and management. | Cancer Metastasis Rev | 2004 | 1.58 |
| 5 | Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. | Clin Cancer Res | 2011 | 1.25 |
| 6 | Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors. | Cancers (Basel) | 2016 | 0.91 |
| 7 | Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. | Biologics | 2015 | 0.85 |